Using a ferromagnetic detection system before MRI may boost safety, detecting implanted or embedded items that may contraindicate the exam.
A ferromagnetic detection system may detect implanted or embedded items in patients referred for MRI examinations, according to a study published in the American Journal of Roentgenology.
Magnetic resonance images are becoming more common, particularly as clinicians try to avoid using CT scans to limit radiation exposure to their patients. However, MRI has its own risks because of ferromagnetic implants or foreign bodies that may be exposed to the powerful magnetic fields.
Researchers from University of Southern California and Loyola Marymount University in Los Angeles investigated the feasibility of using a ferromagnetic detection device to screen patients for implants and foreign objects before undergoing MRI.
Volunteers were recruited for screening with a “pillar-type” ferromagnetic detection device. Sixty-seven different implants and other objects were chosen for testing (43 pulse generators, five electronic devices, six stents, three CSF shut-off valves, three orthopedic implants, four bullets, and three “other). The volunteers were first screened without any ferromagnetic objects on their body. After confirmation of the system’s function, objects were attached to the volunteers’ body in a realistic in situ location.
The tests found 58 true-positive, four true-negative, no false-positive, and five false-negative findings for a sensitivity of 92 percent and specificity of 100 percent.
The researchers concluded that this type of screening may be used not only for detection of external ferromagnetic objects, but also for implanted or embedded items. They suggest further research to determine the system’s use in the clinical setting.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.